GRADED BALLOON DILATION ATRIAL SEPTOSTOMY IN SEVERE PRIMARY PULMONARY-HYPERTENSION - A THERAPEUTIC ALTERNATIVE FOR PATIENTS NONRESPONSIVE TO VASODILATOR TREATMENT
J. Sandoval et al., GRADED BALLOON DILATION ATRIAL SEPTOSTOMY IN SEVERE PRIMARY PULMONARY-HYPERTENSION - A THERAPEUTIC ALTERNATIVE FOR PATIENTS NONRESPONSIVE TO VASODILATOR TREATMENT, Journal of the American College of Cardiology, 32(2), 1998, pp. 297-304
We sought to investigate the acute hemodynamic effects of graded ballo
on dilation atrial septostomy (BDAS) and to define the long-term impac
t of this procedure an New York Heart Association functional class and
survival in adult patients with primary pulmonary hypertension (PPH).
Background. Current treatment strategies for patients with severe and
refractory PPH are limited by either technical difficulties and high
mortality or cost. Methods. We studied 15 patients with severe PPH. BD
AS was successfully performed in all patients by crossing the interatr
ial septum with a Brockenbrough needle, followed by progressive dilati
on of the orifice with a Mansfield balloon in a hemodynamically contro
lled, step-by-step manner. Results. BDAS caused an immediate significa
nt fall in right ventricular end-diastolic pressure and in systemic ar
terial oxygen saturation and an increase in cardiac index. One patient
died, and 14 survived the procedure and significantly improved their
mean functional class (from 3.57 +/- 0.6 to 2.07 +/- 0.3 [mean +/- SD]
, p < 0.001). Exercise endurance (6-min test) also improved from 107 /- 127 to 217 +/- 108 m (p < 0.001). Because of spontaneous closure, B
DAS was repeated in four patients. The survival rate among patients wh
o survived the procedure was 92% at 1, 2 and 3 years, which is better
than that for historical control PPH patients (73%, 59% and 52%, respe
ctively). Conclusions. With careful monitoring, BDAS is a safe and use
ful palliative treatment for selected patients with severe PPH. (C) 19
98 by the American College of Cardiology.